|Bid||254.53 x 800|
|Ask||254.65 x 900|
|Day's Range||251.54 - 255.89|
|52 Week Range||248.41 - 319.76|
|Beta (5Y Monthly)||0.13|
|PE Ratio (TTM)||14.00|
|Earnings Date||Oct 23, 2023 - Oct 27, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||333.66|
Subscribe to Yahoo Finance Plus to view Fair Value for BIIB
Eli Lilly agreed to buy Point Biopharma for $1.4 billion to bolster its cancer drugs business. Is LLY stock a buy right now?
Many retirees are no doubt anxiously awaiting to find out how much their Social Security benefits will increase in 2024. There's another question for which they still don't have an answer: How much will Medicare Part B premiums increase next year? The Centers for Medicare and Medicaid Services (CMS) typically announces the Medicare Part B premiums for the next year sometime between mid-October and early November.
Biogen Inc. (BIIB) closed at $252.86 in the latest trading session, marking a -1.61% move from the prior day.